Abstract

JACC

Lots of interesting abstracts and cases were submitted for TCTAP 2022. Below are the accepted ones after a thorough review by our official reviewers. Don¡¯t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!

TCTAP A-024

Hemodynamic Analysis of New Version Mirage Bioresorbable Scaffold and Metallic Ultimaster Stent: A New Era Begins With Shear Stress Analysis in Stent Assessment

By Erhan Tenekecioglu, Ryo Torii, Solomon Su, Yoshinobu Onuma, Christos V. Bourantas, Patrick W. Serruys

Presenter

Erhan Tenekecioglu

Authors

Erhan Tenekecioglu1, Ryo Torii2, Solomon Su3, Yoshinobu Onuma4, Christos V. Bourantas2, Patrick W. Serruys4

Affiliation

Bursa Yuksek Ihtisas Education and Research Hospital, University of Health Sciences, Turkey1, University College London, United Kingdom2, Dunning Inc, USA3, University of Galway, Ireland4
View Study Report
TCTAP A-024
Basic Science, Animal Models and Preclinical Studies

Hemodynamic Analysis of New Version Mirage Bioresorbable Scaffold and Metallic Ultimaster Stent: A New Era Begins With Shear Stress Analysis in Stent Assessment

Erhan Tenekecioglu1, Ryo Torii2, Solomon Su3, Yoshinobu Onuma4, Christos V. Bourantas2, Patrick W. Serruys4

Bursa Yuksek Ihtisas Education and Research Hospital, University of Health Sciences, Turkey1, University College London, United Kingdom2, Dunning Inc, USA3, University of Galway, Ireland4

Background

Optical Coherence Tomography (OCT) basedcomputational fluid dynamic(CFD) studies have provided enormous information forcoronary flow behaviors at a detailed level that cannot be attainable usingexperimental techniques. Stent implantation causes local flow disruptions whichcan end-up in thrombus formation and exuberant neointimal hyperplasia. Restoring vasomotricity and cyclic strain makes bioresorbable scaffold (BRS) glamorousin front of metallic stents.Afterunprecedented results from Absorb,with circular thinner struts,Mirage seems flashingas an alternative door to knock. In this exploratory analysis,aim was tocompare hemocompatibility of Mirageusing physiologically realistic CFD techniques using preclinical models.

Methods

We analyzed data from Yucatan mini pigs implanted with 3x18mm Ultimaster metallic stent (strut thickness:85µm)(n=6) and 3¡¿18mmMirage Bioresorbable scaffold (BRS) (strut thickness:105µm) (n=6). InUltimaster group, 6 coronary arteries were implanted with a single Ultimasterstent in three animals. In Mirage group, six coronary arteries were implanted with a single Mirage BRS in six animals. Study protocol was approved by the Institutional Animal Care and Use Committee of the testing facility (AccelLABInc., Canada) and were in compliance with the Canadian Council on Animal Care regulations. Animal husbandry, medication administration, and stent implantation were performed according to standards. OCT was performed before and after scaffold implantation in all treated coronary arteries, using a frequency-domain OCT system (C8-XR OCT IntravascularImaging System; St. Jude Medical, USA). Coronary artery reconstruction was conducted implementing a validated methodology. In x-ray angiographic and OCT images, the anatomical landmarks (i.e. side branches) and the radiopaque markers identified both on angiography and OCT, were used to define the scaffolded segment and proximal-distal native vessel segments. In the region of interest (ROI), theOCT images portraying the scaffolded and the proximal-distal non-scaffolded native vessel segments were identified and analyzed at a 100 micron (µm)interval. Two post-procedure end-diastolic angiographic images with at least25¨¬-angle difference showing the ROI with the table in the isocenter were selected. In these images, the luminal borders were delineated for ROI and processed to extract the luminal centerline which was then used for 3D luminal center line of the ROI. The borders of flow area identified on OCT images were then mounted perpendicularly onto the luminal centerline. Following 3D reconstruction of the coronary arteries, endothelial shear stress(ESS) was quantified using Newtonian steady flow simulation in each cross-section in 5-degreesu bunit(sector) of the circumferential luminal surface in CFD models.  Mixed effects models have been implemented for statistical analysis.


Results

Following non-Newtonian pulsatileflow simulation, CFD analysis unraveled that post-implantation shear stressdistribution was comparable between Mirage BRS and metallic DES Ultimaster.Using mixed effect analysis; mean ESS, median ESS, maximum ESS and minimum ESSwere found comparable between Mirage and Ultimaster stent (0.84¡¾0.11 Pa vs0.87¡¾0.09 Pa, p=0.32) (Table) (Figure-1) Theendothelization at 28-day histological analysis showed comparable endothelialcoverage in Mirage BRS and Ultimaster stent. (Figure-2). 
Table: Shear stress results in Miragescaffold and Ultimaster stent
   Total frame number  Max ESS (Pa)  Mean ESS (Pa)  Med ESS (Pa)  Min ESS (Pa)
 Mirage BRS (105 µm)  756  1.92  0.84  0.77 0.22
 Ultimaster (85 µm)  774  1.38  0.87  0.82  0.39
 p-value    0.246  0.88  0.73  0.075



1523-171n_d30-02_rita_dist_low__rec day 0.avi

Conclusion

Invivo 3D-OCT based modeling can be used to evaluate the implications of scaffold configuration on the local hemodynamic forces. The ovoid thin struts, with a helicoidal alignment of the Mirage BRS (Figure-1) appear to have a minimal implication on the ESS patterns compared to the rectangular shaped struts of the Ultimaster metallic stents with a zig-zag with hoops alignment. New thinner version of Mirage bioresorbable scaffold demonstrated similar local micro-hemodynamics with metallic Ultimaster stent. Despite thinner quadraticstruts of Ultimaster, the circular struts of Mirage caused less flow disruption (Figure-2). Further research is required to examine the potential value of the in vivo computational modeling in optimizing scaffold configuration and clinical outcomes. Clinical studies currently conducted, attempt to duplicate the preclinical results Further investigations will demonstrate whether these subtle changes in hemodynamic microenvironment will have clinically significant repercussion on clinical outcome at long term.